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Background: To verify the usefulness of a new algorithm for preoperative diffe-
rential diagnostics of parotid tumours on the basis of their dynamic and diffusion-
-weighted magnetic resonance imaging (MRI).
Materials and methods: The retrospective analysis included 158 consecutive 
surgical patients with parotid tumours. Aside from ultrasound-guided fine 
needle biopsy, the protocol of preoperative evaluation included dynamic and 
diffusion-weighted MRI. According to the new diagnostic algorithm, the result of 
fine needle biopsy was considered only in the case of lesions with time to peak 
enhancement (Tpeak) > 60 s and washout rate (WR) ≤ 30% on dynamic MRI and 
apparent diffusion coefficient (ADC) ≤ 1.7 × 103 mm/s2 on diffusion-weighted 
MRI, or those presenting with concomitant lymphadenopathy. The accuracy of 
this algorithm was verified against final histopathological diagnoses.
Results: The new algorithm gave 10 true positive and 2 false positive results, as 
well as 132 and 14 true and false negative results, respectively. Its sensitivity and 
specificity (41.7% and 98.5%, respectively) were the same as in the case of fine 
needle biopsy alone. None of the 59 tumours that were qualified as benign solely 
on the basis of preoperative MRI turned out to be malignant on postoperative 
histopathological examination.
Conclusions: Interpreted together, dynamic and diffusion-weighted MRIs provide 
the same accuracy in preoperative differential diagnostics of parotid tumours as 
fine needle biopsy. This substantiates the use of diagnostic algorithms in which 
biopsy would serve mostly as a secondary test to verify selected ambiguous ra-
diological diagnoses. (Folia Morphol 2018; 77, 1: 29–35)
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INTRODUCTION
Appropriate qualification for operation is a key 
component of surgical management. This issue be-
comes particularly important in the case of tumour 
resection. While most benign lesions can be subjected 
to local excision, malignant tumours require extended 
resection with a margin of normal tissue. Selection of 
an appropriate surgical technique and defining the 
extent of resection are also important in the case of 
parotid tumours, representing approximately 5% of 
all head and neck neoplasms [15]. The vast majority of 
lesions from this relatively heterogeneous group are 
pleomorphic adenomas and Warthin tumours, usually 
suitable for conservative or even expectant treatment. 
However, also primary or secondary malignancies 
may develop within the parotid gland; suboptimal 
resection of such lesions would have devastating 
consequences [3, 4].
Cytological evaluation of fine needle biopsy speci-
mens constitutes a standard for preoperative dif-
ferential diagnostics of parotid tumours [17]. How-
ever, a growing body of evidence suggest that this 
examination does not provide adequate diagnostic 
accuracy, especially in the case of small and/or deeply 
located lesions. In up to 5% of the cases, material 
obtained during biopsy of such tumours may be not 
representative enough to determine their character 
[6, 14, 16, 23]. Moreover, an incorrectly performed 
biopsy may lead to various complications, including 
systemic spread of cancer cells and ascending infec-
tion of the head and neck [2, 9].
These potential drawbacks of fine needle biopsy 
stimulated interest in dynamic magnetic resonance 
imaging (MRI) and its potential application in the 
preoperative differential diagnostics of parotid tu-
mours. The time intensity curves (TICs) for two most 
common histological types of benign parotid lesions, 
pleomorphic adenomas and Warthin tumours, differ 
from those for parotid malignancies [1, 7–13, 19]. 
A few studies applying this knowledge in differential 
diagnostics of parotid tumours produced promising 
results [18, 20, 21]. However, this evidence, originat-
ing from relatively small studies of patients with pleo-
morphic adenomas, Warthin tumours and parotid 
malignancies, was not confirmed in routine clinical 
practice [5]. Moreover, some empirical data imply that 
parotid malignancies are not homogeneous in terms 
of their presentation on dynamic MRI, and therefore 
some of them may be misdiagnosed as pleomorphic 
adenomas [20].
Since 2013, all patients with parotid tumours 
treated surgically at our centre have been subjected 
to preoperative dynamic and diffusion-weighted MRI 
aside from routine fine needle biopsy. Therefore, we 
have collected a large database of patients in whom 
the result preoperative MRI can be compared with 
final histopathological diagnosis. Similar to previous 
studies, our earlier analyses of this material were 
limited to comparative analysis of MRI parameters 
for pleomorphic adenomas, Warthin tumours and 
parotid malignancies. We showed that dynamic MRI is 
highly accurate in differential diagnostics of Warthin 
tumours and parotid malignancies, but it is diffusion-
weighted MRI which provides optimum accuracy in 
differentiating pleomorphic adenomas from malig-
nant lesions. On the basis of these data, we have 
developed an algorithm for preoperative differential 
diagnostics of parotid tumours based on their pres-
entation on dynamic and diffusion-weighted MRI; 
in this algorithm, the role of fine needle biopsy was 
limited to an adjunct examination performed solely 
in ambiguous cases (Fig. 1). The aim of this study 
was to verify the usefulness of this algorithm in 
a retrospective analysis of more than 150 patients 
with parotid tumours. Contrary to previous studies, 
we analysed all consecutive cases treated at our cen-
tre, also benign lesions with histological types other 
than pleomorphic adenoma or Warthin tumour.
MATERIALS AND METHODS
The retrospective analysis included 158 consecu-
tive patients with parotid tumours treated surgically 
at the Department of Otolaryngology, Medical Uni-
versity of Gdansk, between May 2013 and February 
2015. Aside from ultrasound-guided fine needle bi-
opsy, the protocol of preoperative evaluation included 
also dynamic and diffusion-weighted MRI. However, 
the principal criterion used to determine the type and 
extent of surgical resection was a result of fine needle 
biopsy. Final diagnosis was established on the basis 
of histopathological examination of surgical speci-
men. During the retrospective analysis, however, we 
compared the accuracy of true preoperative diagno-
ses with a hypothetic accuracy of the diagnoses that 
could be established with an aid of the algorithm 
described below, based on the results of dynamic 
and diffusion-weighted MRI.
The protocol of the study was approved by the 
Local Bioethics Committee at the Medical University 
of Gdansk, and all participants gave their written 
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intersection gap, one signal acquired). Gadobutrol 
(Gadovist, Bayer Schering Pharma, Berlin, Germany) 
was administered intravenously at a rate of 2–3 mL/s 
(total dose, 0.1 mmol/kg of body weight), followed by 
a 20-mL saline flush. MRIs were sequentially obtained 
before and 0, 30, 60, 90, 120, 150, 180, 210, 240, 
270, and 300 s after contrast agent administration. 
First observer manually identified regions of interest 
(ROIs) for signal intensity measurements to avoid ves-
sels and cystic parts of the tumours and constructed 
TICs with the use of dedicated software. All MRIs were 
interpreted in consensus by two observers who were 
blinded to clinical information and biopsy results. 
For ADC measurements, the same observer manually 
placed ROIs within a given lesion. Each time, three 
ROIs were placed within the area that corresponded 
to one used for TICs construction, and the obtained 
ADC values were averaged. ADC was calculated with 
linear regression analysis.
Cytological and histological examination
Both the material obtained during preoperative 
fine needle biopsy and the surgical specimens of 
parotid tumours were processed routinely, stained 
with haematoxylin and eosin and subjected to cy-
tological and histological examination under a light 
microscope.
Algorithm for differential diagnostics
During the first stage, we identified benign le-
sions presenting with Warthin tumour-like pheno-
informed consent for all medical procedures, as well 
as for the use of their data for research purposes.
Dynamic and diffusion-weighted MRI
Magnetic resonance examinations were performed 
in a 1.5-T scanner (Magnetom Area, Siemens, Erlan-
gen, Germany) with the use of a head coil. Pre- and 
post-contrast T1-weighted spin-echo (repetition time 
ms/echo time ms, 659/12; 256 × 256 matrix; 5-mm 
section thickness; 2.5-mm intersection gap; 20–25-cm 
field of view; one signal acquired) and pre-contrast 
T2-weighted fast spin-echo (repetition time ms/echo 
time ms, 3680/93; 256 × 256 matrix; 5-mm section 
thickness; 2.5-mm intersection gap; 20–25-cm field 
of view; one signal acquired) images were obtained 
in three orthogonal planes. Subsequently, diffusion 
weighted imaging was performed with a multisec-
tion spin-echo single-shot echoplanar sequence in 
the transverse plane (3200/118, 20–25-cm field of 
view, 128 × 128 matrix, 5-mm section thickness, 
2.5-mm intersection gap, two signals acquired, 48-s 
acquisition time). Sensitising diffusion gradients were 
applied sequentially in the x, y, and z directions with 
b values of 0, 500, and 1000 s/mm2. Apparent diffusion 
coefficient (ADC) maps were generated. During ex-
aminations tumours were identified on the transverse 
T1-weighted images, and three sections, including 
one section that accounted for the maximum diam-
eter of the tumour, were selected for dynamic con-
trast-enhanced MRI (300/13, 20–25-cm field of view, 
256 × 256 matrix, 5-mm section thickness, 2.5-mm 
Figure 1. A scheme illustrating the role of dynamic and diffusion weighted magnetic resonance imaging (MRI) and fine needle biopsy in 
preoperative differential diagnostics of parotid tumours; ADC — apparent diffusion coefficient; WR — washout rate; Tpeak — time to peak 
enhancement.
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type on dynamic MRI. The lesions with time to peak 
enhancement (Tpeak) ≤ 60 s and washout rate (WR) 
> 30% were considered benign, except for those 
in the case of which the presence of concomitant 
lymphadenopathy raised a suspicion of malignant 
transformation; in such cases, final preoperative diag-
nosis was established with fine needle biopsy. During 
the second stage, on the basis of ADC > 1.7 × 103 
mm/s2 documented on diffusion-weighted MRI, we 
identified the masses presenting with pleomorphic 
adenoma-like phenotype. Similar to the first stage, 
a result of fine needle biopsy was considered the final 
preoperative diagnosis in the case of lesions with ADC 
> 1.7 × 103 mm/s2 and concomitant lymphadenopa-
thy. Consequently, fine needle biopsy was used to 
establish the final preoperative diagnosis for tumours 
with Tpeak > 60 s, WR ≤ 30% and ADC ≤ 1.7 × 10
3 
mm/s2, as well as for the remaining lesions presenting 
with concomitant lymphadenopathy (Fig. 1).
Statistical analysis
During statistical analysis, the accuracy of truly 
used diagnostic algorithm based on fine needle biop-
sy was compared with the accuracy of the algorithm 
presented above, based on the results of dynamic and 
diffusion-weighted MRI. Sensitivity and specificity of 
both algorithms in identification of parotid malig-
nancies were calculated, along with the areas under 
their ROC curves (AUCs, with their 95% confidence 
intervals [95% CI]). True/false positive and negative 
rates were calculated in relation to a gold standard, 
the result of final histopathological examination. All 
calculations were carried out with Statistica 10 pack-
age (StatSoft, Tulsa OK, USA), with the threshold of 
statistical significance set at p ≤ 0.05.
RESULTS
Histopathological examination of the surgical 
specimens showed that the analysed material includ-
ed 24 parotid malignancies (15%) and 134 benign 
or non-neoplastic lesions (85%). The group of malig-
nancies included adenocarcinomas (n = 6), myoepi-
thelial carcinomas (n = 4), metastases from other 
sites (n = 4), mucoepidermoid carcinomas (n = 2), 
adenoid cystic carcinomas (n = 2), acinic cell carcino- 
mas (n = 2), lymphomas (n = 2), ductal carcinoma 
(n = 1) and planoepithelial carcinoma (n = 1). The 
group of benign tumours and non-neoplastic le-
sions was comprised of pleomorphic adenomas 
(n = 57), Warthin tumours (n = 52) and sporadic cases 
of other tumours, cysts, inflammatory lesions, etc. 
(n = 25).
Based on the result of fine needle biopsy, 12 (8%) 
parotid lesions were identified as malignant tumours. 
This group included 10 true positive diagnoses and 
2 false positive ones, which corresponded to 41.7% 
sensitivity. The number of true and false negative di-
agnoses was 132 and 14, respectively, corresponding 
to 98.5% specificity. The area under ROC curve for 
fine needle biopsy was 0.701 (95% CI 0.566–0.836).
A total of 28 (18%) lesions were considered benign 
on the basis of preoperative dynamic MRI (Tpeak ≤ 60 s 
and WR > 30%). Due to presence of concomitant 
lymphadenopathy, final preoperative diagnosis for 
13 out of the 28 (46%) potentially benign masses 
was established on the basis of fine needle biopsy. 
In all these cases, cytological diagnosis was con-
sistent with the radiological one, confirming be-
nign character of the lesions. However, one tumour 
qualified as benign on the basis of both dynamic 
MRI and fine needle biopsy eventually turned out 
to be malignant on postoperative histopathologi-
cal examination (1 false negative result). When the 
results of diffusion-weighted MRI (ADC > 1.7 × 103 
mm/s2) were applied, 44 out of the 130 lesions 
non-classified on the basis of dynamic MRI (34%) 
were identified as benign. This subset included 
13 (30%) lesions with concomitant lymphadenopathy, 
in the case of which the final preoperative diagnosis 
was established on the basis of fine needle biopsy. 
In one of these cases, a malignancy was identified 
during examination of the biopsy specimen. In the 
remaining 12 cases, the result of cytological exami-
nation was consistent with the diagnosis established 
on diffusion-weighted MRI. Preoperative diagnoses 
established on the basis of diffusion-weighted MRI 
and fine needle biopsy were in complete agreement 
with the results of postoperative histopathological 
examination. Fine needle biopsy was used to estab-
lish the final preoperative diagnoses for the remain-
ing 86 lesions. In 11 (13%) cases, a malignancy was 
found on cytological examination. In 9 out of the 
11 tumours, this diagnosis was consistent with the 
result of final histopathological examination (2 false 
positive results). However, the subset of 75 lesions 
that were diagnosed as benign during preopera-
tive cytological examination included as many as 
13 tumours that eventually turned out to be malig-
nant (13 false negative results). All these data are 
presented schematically on Figure 2.
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Overall, the algorithm based on the results of 
dynamic and diffusion-weighted MRI supported with 
fine needle biopsy gave 10 true positive and 2 false 
positive results, as well as 132 and 14 true and false 
negative results, respectively. This corresponded to 
41.7% sensitivity and 98.5% specificity of the algo-
rithm in differential diagnostics of parotid tumours. 
The area under ROC curve for the algorithm was 0.701 
(95% CI 0.566–0.836). All measures of diagnostic 
accuracy mentioned above were exactly the same as 
those calculated for fine needle biopsy alone.
The subset of 14 parotid malignancies, in the case 
of which the hereby presented diagnostic algorithm 
produced false negative results, included 11 lesions 
with concomitant lymphadenopathy. Lymphadenopa-
thy was in turn absent in the case of two benign 
lesions for which our algorithm produced false posi-
tive results.
DISCUSSION
Potential application of dynamic MRI to the differ-
ential diagnostics of parotid tumours was postulated 
already more than two decades ago. A number of 
authors showed that the shape of TIC can be used 
to distinguish parotid malignancies, characterised 
by an early enhancement and a gradual washout 
of the contrast (i.e. short Tpeak and high WR) from 
pleomorphic adenomas (with a gradual enhancement 
and a slow washout, i.e. long Tpeak and high WR) 
and Warthin tumours (with an early enhancement 
and a rapid washout, i.e. short Tpeak and low WR) 
[1, 7–10, 12, 13, 19]. However, further research on the 
cut-off values for Tpeak and WR providing maximum 
accuracy in the differential diagnostics of these three 
groups produced conflicting results. While there is 
a consensus with regards to the cut-off values for 
Tpeak and WR that accurately distinguish parotid 
malignancies from Warthin tumours (Tpeak = 60 s 
and WR = 30%) [9, 18, 20, 21], the differential 
diagnostics of pleomorphic adenomas and malig-
nant lesions is still a challenge. Clinical experience 
suggests that the previously proposed cut-off val-
ues for Tpeak (120, 210 or 240 s) and WR (10%) 
[9, 18, 20, 21] are not accurate enough to distinguish 
malignant tumours from pleomorphic adenomas. 
Moreover, the TICs for some parotid malignancies 
resemble those traditionally assigned to pleomor-
phic adenomas [20]. Therefore, some authors pos-
tulated that these two types of lesions should be 
distinguished on the basis of their ADC values de-
termined on diffusion-weighted MRI. Previous stud-
ies identified two cut-off values for ADC providing 
Figure 2. Results of preoperative differential diagnostics with the algorithm based on the results of dynamic and diffusion-weighted magnetic 
resonance imaging (MRI). Numbers in parentheses represent false negative (highlighted in red) and false positive diagnoses (highlighted in 
green); ADC — apparent diffusion coefficient; WR — washout rate; Tpeak — time to peak enhancement.
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optimum accuracy in the differential diagnostics 
of pleomorphic adenomas and parotid malignancies: 
1.4 × 103 mm2/s and 1.8 × 103 mm2/s [5, 22].
Limitations of the study
An important limitation of all the studies men-
tioned above was small number of examined parotid 
tumours. Having access to markedly larger group of 
patients, we were able to verify diagnostic accuracy 
of the previously proposed cut-off values for MRI 
parameters, and to develop our own diagnostic algo-
rithm, presented in this paper. Moreover, we observed 
that most parotid malignancies were associated with 
concomitant lymphadenopathy, and inclusion of this 
parameter in our diagnostic algorithm resulted in 
further increase in its accuracy. These yet unpublished 
observations were confirmed in this study, as the 
accuracy of our algorithm turned out to be exactly 
the same as the accuracy of fine needle biopsy, still 
considered a gold standard for preoperative diagnos-
tics of parotid tumours. Although we still used fine 
needle biopsy to verify some of the radiological di-
agnoses, the subset of 72 parotid tumours that were 
identified as benign solely on the basis of dynamic 
(n = 28) or diffusion-weighted MRI (n = 44) included 
only two masses that eventually turned out to be 
malignant. The remaining false negative diagnoses 
(n = 13) were established in the case of masses that 
were considered potentially malignant on the basis 
of preoperative MRI but were eventually qualified 
as benign based on the result of fine needle biopsy.
Consequently, a question arises whether dynamic 
and diffusion-weighted MRI may replace fine needle 
biopsy in the preoperative differential diagnostics of 
parotid tumours? The list of arguments for routine 
use of dynamic and diffusion-weighted MRI includes 
more objective character of diagnostic imaging, less 
steep learning curve and lower risk of complications 
than in the case of fine needle biopsy. However, it 
should be remembered that imaging studies are with 
no doubt markedly more expensive than the biopsy 
and their availability is typically limited to tertiary cen-
tres. Moreover, also dynamic and diffusion-weighted 
MRI is associated with some subjectivity, for example, 
associated with the selection of ROI. Furthermore, 
one should remember that it was fine needle biopsy 
which enabled us to verify a false negative diagnosis 
established on the basis of diffusion-weighted MRI 
in one of the hereby presented cases. Altogether, this 
suggests that with the current state of knowledge, 
dynamic and diffusion-weighted MRI and fine nee-
dle biopsy should be considered as complementary 
examinations in differential diagnostics of parotid 
tumours. Nevertheless, the results of this study imply 
also that due to its comparative accuracy but poten-
tially greater invasiveness, fine needle biopsy could 
be used predominantly as a secondary test to verify 
selected ambiguous radiological diagnoses.
Our findings point also to directions of future 
research on the optimisation of differential diagnos-
tics of parotid tumours. Such studies should centre 
around further improvement of algorithms based on 
dynamic and diffusion-weighted MRI, e.g. by inclu-
sion additional clinical parameters. Such direction 
of future research seems justified since most false 
negative and false positive diagnoses established 
in our study could be corrected if the presence of 
concomitant lymphadenopathy or lack thereof were 
considered. Our experience suggests that also other 
clinical and demographic parameters, e.g. involve-
ment of the deep parotid lobe and older age of the 
patient, may imply malignant character of a tumour. 
Another domain of future research should be com-
parative cost-effectiveness analysis of fine needle 
biopsy, dynamic and diffusion-weighted MRI and 
diagnostic algorithms combining all these methods. 
In other words, one should verify if greater accuracy 
of preoperative diagnostics, achieved due to imple-
mentation of novel MRI technologies, is reflected by 
a reduction of treatment costs.
CONCLUSIONS
Interpreted together, the results of dynamic and 
diffusion-weighted MRI provide the same accuracy 
in preoperative differential diagnostics of parotid 
tumours as fine needle biopsy. Taking into account 
previously documented drawbacks of the latter, 
this observation substantiates the use of diagnostic 
algorithms in which biopsy would serve mostly as 
a secondary test to verify selected ambiguous radio-
logical diagnoses.
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